Biora Therapeutics, Inc. (BIOR)
BIOR Stock Price Chart
Explore Biora Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze BIOR price movements and trends.
BIOR Company Profile
Discover essential business fundamentals and corporate details for Biora Therapeutics, Inc. (BIOR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Jun 2020
Employees
58.00
CEO
Aditya P. Mohanty
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
BIOR Financial Timeline
Browse a chronological timeline of Biora Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Nov 2025
Earnings released on 19 Jun 2025
Earnings released on 29 May 2025
Earnings released on 25 Mar 2025
Earnings released on 14 Nov 2024
EPS came in at -$6.08 falling short of the estimated -$3.85 by -57.92%, while revenue for the quarter reached $32.00K , missing expectations by -86.09%.
Stock split effective on 18 Oct 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Aug 2024
EPS came in at -$3.50 surpassing the estimated -$4.50 by +22.22%, while revenue for the quarter reached $318.00K .
Earnings released on 15 May 2024
EPS came in at -$6.10 falling short of the estimated -$4.50 by -35.56%, while revenue for the quarter reached $542.00K .
Earnings released on 26 Mar 2024
EPS came in at -$6.30 falling short of the estimated -$6.00 by -5.00%, while revenue for the quarter reached $872.00K , beating expectations by +174.30K%.
Earnings released on 13 Nov 2023
EPS came in at -$7.50 surpassing the estimated -$9.30 by +19.35%.
Earnings released on 14 Aug 2023
EPS came in at -$14.70 surpassing the estimated -$16.00 by +8.13%, while revenue for the quarter reached $2.00K , missing expectations by -90.00%.
Earnings released on 15 May 2023
EPS came in at -$15.90 falling short of the estimated -$1.75 by -808.57%, while revenue for the quarter reached $2.00K .
Earnings released on 30 Mar 2023
EPS came in at -$16.10 falling short of the estimated -$8.90 by -80.90%, while revenue for the quarter reached $14.00K , missing expectations by -72.00%.
Stock split effective on 3 Jan 2023
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2022
EPS came in at -$20.00 falling short of the estimated -$15.00 by -33.33%, while revenue for the quarter reached $80.00K , missing expectations by -20.00%.
Earnings released on 15 Aug 2022
EPS came in at -$7.50 surpassing the estimated -$32.50 by +76.92%, while revenue for the quarter reached $104.00K .
Earnings released on 10 May 2022
EPS came in at -$30.00 matching the estimated -$30.00, while revenue for the quarter reached $107.00K , meeting expectations.
Earnings released on 28 Mar 2022
EPS came in at -$14.00 falling short of the estimated -$4.00 by -250.00%, while revenue for the quarter reached $435.00K , beating expectations by +74.00%.
Earnings released on 10 Nov 2021
EPS came in at -$11.50 falling short of the estimated -$11.17 by -2.95%, while revenue for the quarter reached $182.00K .
Earnings released on 12 Aug 2021
EPS came in at -$16.25 surpassing the estimated -$20.17 by +19.43%, while revenue for the quarter reached $463.00K .
Earnings released on 13 May 2021
EPS came in at -$14.00 surpassing the estimated -$20.30 by +31.03%, while revenue for the quarter reached $24.53M .
Earnings released on 18 Mar 2021
EPS came in at -$38.25 falling short of the estimated -$20.55 by -86.13%, while revenue for the quarter reached $14.28M .
Earnings released on 9 Nov 2020
EPS came in at -$25.25 falling short of the estimated -$17.90 by -41.06%, while revenue for the quarter reached $25.94M .
BIOR Stock Performance
Access detailed BIOR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.